[HTML][HTML] Trends in pancreatic cancer incidence, characteristics, and outcomes in Denmark 1980–2019: A nationwide cohort study
J Kirkegård, AB Bojesen, MF Nielsen… - Cancer epidemiology, 2022 - Elsevier
Objective To describe time-trends in incidence, characteristics, treatments, and survival in
pancreatic cancer patients in Denmark during 1980–2019. Design A nationwide population …
pancreatic cancer patients in Denmark during 1980–2019. Design A nationwide population …
Effect of surgery versus chemotherapy in pancreatic cancer patients: a target trial emulation
J Kirkegård, C Gaber… - JNCI: Journal of the …, 2024 - academic.oup.com
Background To estimate the causal effect of surgery vs chemotherapy on survival in patients
with T1-3NxM0 pancreatic cancer in a rigorous framework addressing selection bias and …
with T1-3NxM0 pancreatic cancer in a rigorous framework addressing selection bias and …
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic …
LS Rasmussen, SB Winther, IM Chen, B Weber… - BMC cancer, 2023 - Springer
Background According to current evidence, the best treatment for fit patients with non-
resectable pancreatic cancer (PC) is combination chemotherapy, whereas frail patients are …
resectable pancreatic cancer (PC) is combination chemotherapy, whereas frail patients are …
Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital
M Ladekarl, AK Nøhr, M Sønderkær, SC Dahl… - Acta …, 2023 - Taylor & Francis
Aim Our goal was to describe a precision medicine program in a regional academic hospital,
characterize features of included patients and present early data on clinical impact …
characterize features of included patients and present early data on clinical impact …
Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life
Introduction Cisplatin, nab-paclitaxel, capecitabine, and gemcitabine (PAXG) regimen
activity was assessed in a single institution phase II trial (PACT-19) on pancreatic ductal …
activity was assessed in a single institution phase II trial (PACT-19) on pancreatic ductal …
Changing before we have to; how to mitigate disparities in pancreatic cancer care?
M Nilbert - Acta Oncologica, 2022 - Taylor & Francis
Incidence rates and death rates from pancreatic cancer are increasing, primarily due to
smoking, high plasma glucose, and high body-mass index. The number of incident cases …
smoking, high plasma glucose, and high body-mass index. The number of incident cases …
[PDF][PDF] Dansk Pancreas Cancer Database (DPCD)–Resumé af Årsrapport 2020/2021
FVM Fallentin, I Chen, JP Hasselby, LP Larsen… - content.ugeskriftet.dk
DPCD blev etableret 1. maj 2011 og inkluderer populationen af patienter med en ICD-10-
diagnose svarende til en tumor i pancreas, papil og duodenum. Omkring 1.050 patienter …
diagnose svarende til en tumor i pancreas, papil og duodenum. Omkring 1.050 patienter …